SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

More than a quarter of us have learned all we know about weight-loss jabs through social media, so GP Dr Bryony Henderson has helped clear up the myths and misunderstandings ...

Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure with ...

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

For those who have struggled with the scale, the treatments can help achieve results and improve overall health (and do so ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Estrogen is the primary culprit for weight gain in the hips, thighs and buttocks. The ovaries produce less estrogen during ...

CHICAGO, IL—The weight-loss medication tirzepatide (Eli Lilly) significantly cut the risk of cardiovascular mortality and ...